解读2007年ESH/ESC高血压指南

被引：29

作者：

马长生

乔岩

机构：

[1] 首都医科大学附属北京安贞医院

来源：

中国实用内科杂志 | 2009年 / 29卷 / 09期

关键词：

高血压; 指南;

D O I：

暂无

中图分类号：

R544.1 [高血压];

学科分类号：

1002 ; 100201 ;

摘要：

2007年,欧洲高血压学会和欧洲心脏学会(ESH/ESC)联合公布了高血压诊治新指南,从全面评估、治疗方法与策略以及特殊人群的处理等方面的集中反映了高血压最新进展,更新了评估指标,强调了及早降压,更严格更快降压和强化联合治疗的重要性,要求防治重心前移。新的指南对目前高血压的诊治具有重要的指导意义。

引用

页码：798 / 800+882 +882

页数：4

共 10 条

[1] Predictors of adverse outcome among patients with hypertension and coronary artery disease [J].

Pepine, CJ ;

Kowey, PR ;

Kupfer, S ;

Kolloch, RE ;

Benetos, A ;

Mancia, G ;

Coca, A ;

Cooper-DeHoff, RM ;

Handberg, E ;

Gaxiola, E ;

Sleight, P ;

Conti, CR ;

Hewkin, AC ;

Tavazzi, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (03) :547-551

[2]

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B. Dahlof B,Sever PS,Poulter NR, et al. Lancet,The . 2005

[3]

Blood pressure dependent andindependent effects of antihypertensive treatment on clinical events inthe Value trial. Weber M A,Julius S,Kjeldsen S E,et al. The Lancet . 2004

[4]

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial[J] . Stevo Julius,Sverre E Kjeldsen,Michael Weber,Hans R Brunner,Steffan Ekman,Lennart Hansson,Tsushung Hua,John Laragh,Gordon T McInnes,Lada Mitchell,Francis Plat,Anthony Schork,Beverly Smith,Alberto Zanchetti. &nbspThe Lancet . 2004 (9426)

[5]

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial. Julius S,Kjeldsen SE,Weber M,et al. The Lancet . 2004

[6]

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Yusuf S,Pfeffer MA,Swedberg K,et al. The Lancet . 2003

[7]

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. The Journal of The American Medical Association . 2000

[8]

2007Guidelines for the management of arterial hypertension:The Task Force for the Manage-ment of Arterial Hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC). Mancia G,De Backer G,Dominiczak A,et al. European Heart Journal . 2007

[9]

Predictors of adverse outcome among patients with hypertension and coronary artery disease. Pepine CJ,Kowey PR,Kupfer S,et al. Journal of the American College of Cardiology . 2006

[10] Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial [J].